Faruqi & Faruqi Investigates Potential Claims Against Varonis Systems
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 29 2026
0mins
Should l Buy VRNS?
Source: PRnewswire
- Legal Investigation Initiated: Faruq & Faruqi, LLP is investigating potential claims against Varonis Systems, Inc., particularly for investors who purchased or acquired securities between February 4, 2025, and October 28, 2025, highlighting a commitment to protecting investor rights.
- Investor Rights Reminder: The firm reminds investors that March 9, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, a time constraint that could affect investors' legal options and potential recoveries.
- Direct Contact Channels: Securities Litigation Partner Josh Wilson encourages affected investors to contact him directly, providing multiple contact numbers for consultations, demonstrating a commitment to client service and support.
- Potential Market Impact: This investigation may negatively impact Varonis's stock price, prompting investors to monitor subsequent legal developments to assess the risks and potential losses associated with their investments.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VRNS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VRNS
Wall Street analysts forecast VRNS stock price to rise
18 Analyst Rating
14 Buy
4 Hold
0 Sell
Strong Buy
Current: 23.950
Low
37.00
Averages
52.18
High
80.00
Current: 23.950
Low
37.00
Averages
52.18
High
80.00
About VRNS
Varonis Systems, Inc. is a data security company. The Company’s cloud-native data security platform discovers and classifies critical data, removes exposures, and detects advanced threats with artificial intelligence (AI)-powered automation. Varonis software enables enterprises of all sizes and industries to protect data stored in the cloud and on-premises, including sensitive files, emails and databases; confidential personal data belonging to customers, patients and employees; financial records; source code, strategic and product plans; and other intellectual property. Its SaaS product portfolio includes two product lines: its flagship Varonis Data Security Platform, which protects Microsoft 365, Windows file shares, Active Directory, Edge devices (VPN, DNS, proxy), UNIX/Linux and hybrid NAS storage, and DatAdvantage Cloud, which protects IaaS environments and SaaS applications, such as Salesforce, AWS, Azure, Google Cloud, Google Workspace, Databricks, ServiceNow, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Tremblant Capital Increases Stake in Varonis Systems
- Share Acquisition: On February 17, 2026, Tremblant Capital Group disclosed the acquisition of 3,058,524 shares of Varonis Systems, with an estimated transaction value of approximately $128.40 million, indicating confidence in the company's future.
- Ownership Proportion: Following this acquisition, Varonis represented 2.94% of Tremblant Capital's 13F reportable assets, highlighting its significance within the investment portfolio.
- Market Performance: As of February 17, 2026, Varonis shares were priced at $25.32, down about 40% over the past year, significantly lagging behind the S&P 500's roughly 20% gain during the same period, reflecting market concerns about its growth prospects.
- Revenue Growth: Despite challenges, Varonis generated approximately $623.5 million in revenue in 2025, a 13% year-over-year increase, while annual recurring revenue reached about $745 million, indicating the potential of its transition to a SaaS model.
See More
Tremblant Capital Increases Stake in Varonis Systems
- Stake Increase: Tremblant Capital Group increased its stake in Varonis Systems by 3,058,524 shares in Q4 2025, with an estimated trade value of $128.40 million, indicating confidence in the company's growth potential.
- Quarter-End Position Value: As of December 31, 2025, Tremblant's position in Varonis was valued at $115.12 million, reflecting a net increase of $89.19 million due to both stock price appreciation and additional share purchases.
- Revenue Growth Trend: Varonis generated approximately $623.5 million in revenue for 2025, a 13% year-over-year increase, while annual recurring revenue reached about $745 million, showcasing the company's potential in transitioning to a SaaS model.
- Market Reaction and Investor Confidence: Despite a nearly 50% stock price drop last year due to lowered full-year guidance, Tremblant's stake increase signals investor confidence in Varonis's long-term growth prospects, particularly amid rising demand for data security solutions.
See More
Class Action Lawsuits Filed Against Varonis and Ardent Health
- Varonis Lawsuit Overview: Shareholders of Varonis Systems, Inc. are facing losses from February 4 to October 28, 2025, due to the company's failure to disclose its ability to sustain growth, leading to a misunderstanding of its prospects, with a class action deadline of March 9, 2026.
- Ardent Lawsuit Details: Similarly, shareholders of Ardent Health, Inc. from July 18, 2024, to November 12, 2025, encountered issues as the company misrepresented the collectability of accounts receivable, resulting in a misjudgment of its financial health, with the same class action deadline of March 9, 2026.
- Legal Consultation Advice: The Law Offices of Frank R. Cruz remind investors who suffered losses during the specified periods to contact the firm to understand their legal rights, providing contact details including phone and email.
- Class Action Participation Note: Investors need not take immediate action to be part of the class action, and the law firm offers various contact methods for shareholders to obtain more information and consultation.
See More
Varonis Systems Faces Class Action Lawsuit Reminder
- Class Action Notice: The Schall Law Firm reminds investors of a class action lawsuit against Varonis Systems for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between February 4 and October 28, 2025.
- False Statement Allegations: The complaint alleges that Varonis made overly optimistic claims about its ability to convert existing customers to its SaaS offering, while struggling to persuade customers to switch, thereby reducing opportunities for annual recurring revenue growth.
- Investor Losses: As the market learned the truth about Varonis, investors suffered damages, indicating that the company's public statements were false and materially misleading throughout the class period.
- Legal Consultation Opportunity: The Schall Law Firm encourages affected investors to contact them before March 9, 2026, to discuss their rights and participate in the lawsuit, noting that the class has not yet been certified, meaning investors are not represented by an attorney until then.
See More
Reminder of Varonis Systems Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Varonis Systems (NASDAQ:VRNS) common stock between February 4, 2025, and October 28, 2025, that the deadline to apply as lead plaintiff is March 9, 2026, allowing potential compensation without out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Varonis failed to maintain annual recurring revenue (ARR) projections and could not effectively persuade existing customers to transition to the software-as-a-service (SaaS) model, resulting in significantly reduced ARR growth potential and investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, recovering over $438 million for investors in 2019, showcasing its strong track record in this field.
- Participation Instructions: Investors can join the class action by visiting the specified website or calling the toll-free number, and while the class has not yet been certified, they may choose to retain counsel or remain absent members without taking action, with future recovery not dependent on being a lead plaintiff.
See More
Varonis Systems Faces Class Action for Securities Fraud
- Class Action Initiation: Robbins Geller law firm announces that investors who purchased Varonis Systems (NASDAQ: VRNS) stock between February 4, 2025, and October 28, 2025, have until March 9, 2026, to apply as lead plaintiffs in the class action lawsuit, highlighting significant investor concern over the company's financial transparency.
- Allegations of the Lawsuit: The lawsuit accuses Varonis and its executives of violating the Securities Exchange Act of 1934 by creating false impressions regarding their revenue outlook and growth expectations, leading investors to make uninformed decisions, which reflects serious deficiencies in corporate governance and information disclosure.
- Impact of Stock Price Plunge: Following the release of third-quarter results on October 28, 2025, which fell significantly short of expectations, Varonis's stock price plummeted nearly 49%, adversely affecting investor confidence and potentially placing the company at a disadvantage in future financing and market competition.
- Legal Process Overview: Under the Private Securities Litigation Reform Act of 1995, any investor who purchased Varonis stock during the class period can seek to be appointed as lead plaintiff, representing all other investors in the lawsuit, demonstrating the legal system's emphasis on protecting investor rights.
See More
Tremblant Capital Increases Stake in Varonis Systems
- Share Acquisition: On February 17, 2026, Tremblant Capital Group disclosed the acquisition of 3,058,524 shares of Varonis Systems, with an estimated transaction value of approximately $128.40 million, indicating confidence in the company's future.
- Ownership Proportion: Following this acquisition, Varonis represented 2.94% of Tremblant Capital's 13F reportable assets, highlighting its significance within the investment portfolio.
- Market Performance: As of February 17, 2026, Varonis shares were priced at $25.32, down about 40% over the past year, significantly lagging behind the S&P 500's roughly 20% gain during the same period, reflecting market concerns about its growth prospects.
- Revenue Growth: Despite challenges, Varonis generated approximately $623.5 million in revenue in 2025, a 13% year-over-year increase, while annual recurring revenue reached about $745 million, indicating the potential of its transition to a SaaS model.
See More
Tremblant Capital Increases Stake in Varonis Systems
- Stake Increase: Tremblant Capital Group increased its stake in Varonis Systems by 3,058,524 shares in Q4 2025, with an estimated trade value of $128.40 million, indicating confidence in the company's growth potential.
- Quarter-End Position Value: As of December 31, 2025, Tremblant's position in Varonis was valued at $115.12 million, reflecting a net increase of $89.19 million due to both stock price appreciation and additional share purchases.
- Revenue Growth Trend: Varonis generated approximately $623.5 million in revenue for 2025, a 13% year-over-year increase, while annual recurring revenue reached about $745 million, showcasing the company's potential in transitioning to a SaaS model.
- Market Reaction and Investor Confidence: Despite a nearly 50% stock price drop last year due to lowered full-year guidance, Tremblant's stake increase signals investor confidence in Varonis's long-term growth prospects, particularly amid rising demand for data security solutions.
See More
Class Action Lawsuits Filed Against Varonis and Ardent Health
- Varonis Lawsuit Overview: Shareholders of Varonis Systems, Inc. are facing losses from February 4 to October 28, 2025, due to the company's failure to disclose its ability to sustain growth, leading to a misunderstanding of its prospects, with a class action deadline of March 9, 2026.
- Ardent Lawsuit Details: Similarly, shareholders of Ardent Health, Inc. from July 18, 2024, to November 12, 2025, encountered issues as the company misrepresented the collectability of accounts receivable, resulting in a misjudgment of its financial health, with the same class action deadline of March 9, 2026.
- Legal Consultation Advice: The Law Offices of Frank R. Cruz remind investors who suffered losses during the specified periods to contact the firm to understand their legal rights, providing contact details including phone and email.
- Class Action Participation Note: Investors need not take immediate action to be part of the class action, and the law firm offers various contact methods for shareholders to obtain more information and consultation.
See More
Varonis Systems Faces Class Action Lawsuit Reminder
- Class Action Notice: The Schall Law Firm reminds investors of a class action lawsuit against Varonis Systems for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between February 4 and October 28, 2025.
- False Statement Allegations: The complaint alleges that Varonis made overly optimistic claims about its ability to convert existing customers to its SaaS offering, while struggling to persuade customers to switch, thereby reducing opportunities for annual recurring revenue growth.
- Investor Losses: As the market learned the truth about Varonis, investors suffered damages, indicating that the company's public statements were false and materially misleading throughout the class period.
- Legal Consultation Opportunity: The Schall Law Firm encourages affected investors to contact them before March 9, 2026, to discuss their rights and participate in the lawsuit, noting that the class has not yet been certified, meaning investors are not represented by an attorney until then.
See More
Reminder of Varonis Systems Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Varonis Systems (NASDAQ:VRNS) common stock between February 4, 2025, and October 28, 2025, that the deadline to apply as lead plaintiff is March 9, 2026, allowing potential compensation without out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Varonis failed to maintain annual recurring revenue (ARR) projections and could not effectively persuade existing customers to transition to the software-as-a-service (SaaS) model, resulting in significantly reduced ARR growth potential and investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, recovering over $438 million for investors in 2019, showcasing its strong track record in this field.
- Participation Instructions: Investors can join the class action by visiting the specified website or calling the toll-free number, and while the class has not yet been certified, they may choose to retain counsel or remain absent members without taking action, with future recovery not dependent on being a lead plaintiff.
See More
Varonis Systems Faces Class Action for Securities Fraud
- Class Action Initiation: Robbins Geller law firm announces that investors who purchased Varonis Systems (NASDAQ: VRNS) stock between February 4, 2025, and October 28, 2025, have until March 9, 2026, to apply as lead plaintiffs in the class action lawsuit, highlighting significant investor concern over the company's financial transparency.
- Allegations of the Lawsuit: The lawsuit accuses Varonis and its executives of violating the Securities Exchange Act of 1934 by creating false impressions regarding their revenue outlook and growth expectations, leading investors to make uninformed decisions, which reflects serious deficiencies in corporate governance and information disclosure.
- Impact of Stock Price Plunge: Following the release of third-quarter results on October 28, 2025, which fell significantly short of expectations, Varonis's stock price plummeted nearly 49%, adversely affecting investor confidence and potentially placing the company at a disadvantage in future financing and market competition.
- Legal Process Overview: Under the Private Securities Litigation Reform Act of 1995, any investor who purchased Varonis stock during the class period can seek to be appointed as lead plaintiff, representing all other investors in the lawsuit, demonstrating the legal system's emphasis on protecting investor rights.
See More
